Relationship between postprandial glucose level and carotid artery stiffness in patients without diabetes or cardiovascular disease

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Watanabe, Kentaro ^a   Suzuki, Tatsuya ^a   Ouchi, Motoshi ^a   Suzuki, Kazunari ^a   Ohara, Makoto ^a   Hashimoto, Masao ^a   Yamashita, Hidetoshi ^a   Okazaki, Masaru ^a   Ishii, Kazuhito ^a   Oba, Kenzo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

1,5 anhydroglucitol; Nondiabetic patients; Postprandial glucose; Pulsatility index

Indexed keywords

1,5 ANHYDROSORBITOL; GLUCOSE;

AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERIOGRAPHY; CAROTID ARTERY PULSE; CLINICAL EVALUATION; COMMON CAROTID ARTERY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DEOXYGLUCOSE; FEMALE; HUMANS; HYPERGLYCEMIA; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84874200045     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-11     Document Type: Article

References (42)

1. The DECODE study group on behalf of the European Diabetes Epidemiology Group Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 1999, 354:617-621. The DECODE study group on behalf of the European Diabetes Epidemiology Group.
2. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004, 164:2090-2095. 10.1001/archinte.164.19.2090, 15505121.
3. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003, 290:486-494. 10.1001/jama.290.4.486, 12876091.
4. Watanabe K, Oba K, Suzuki T, Ouchi M, Suzuki K, Futami-Suda S, Sekimizu K, Yamamoto N, Nakano H. Oral glucose loading attenuates endothelial function in normal individual. Eur J Clin Invest 2011, 41:465-473. 10.1111/j.1365-2362.2010.02424.x, 21128931.
5. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 2010, 74:24-33. 10.1253/circj.CJ-09-0534, 19920359.
6. Ter Avest E, Stalenhoef AF, de Graaf J. What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction?. Clin Sci 2007, 112:507-516. 10.1042/CS20060228, 17419684.
7. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006, 37:87-92.
8. Frauchiger B, Bock A, Eichlisberger R, Landmann J, Thiel G, Mihatsch MJ, Jäger K. The value of different resistance parameters in distinguishing biopsy-proved dysfunction of renal allografts. Nephrol Dial Transplant 1995, 10:527-532.
9. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Diabetol Int 2010, 1:2-20.
10. Watanabe K, Suzuki T, Nakano H, Oba K. Usefulness of carotid parameters measured by ultrasonography as a marker of atherothrombotic infarction and lacunar infarction in high-risk elderly people. Geriatr Gerontol Int 2006, 6:87-93.
11. O'Leary DH, Polak JF, Wolfson SK, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA. Use of sonography to evaluate carotid atherosclerosis in the elderly, the Cardiovascular Health Study. Stroke 1991, 22:1155-1163. 10.1161/01.STR.22.9.1155, 1926258.
12. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, Hori S, Yamamoto Y, Doba N, Hinohara S. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 2003, 166:303-309. 10.1016/S0021-9150(02)00332-5, 12535743.
13. Stickle D, Turk J. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol 1997, 273:E821-E830.
14. Kim WJ, Park CY. 1,5-Anhydroglucitol in diabetes mellitus. Endocrine 2013, 43:33-40. 10.1007/s12020-012-9760-6, 22847316.
15. Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, Akaoka L, Miyashita H. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 1996, 347:1514-1518. 10.1016/S0140-6736(96)90672-8, 8684103.
16. Yamanouchi T, Akanuma Y. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control. Diabetes Res Clin Pract 1994, 24:S261-S268.
17. Yoshioka K, Azukari K, Yoshida T, Kondo M. Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of α-glucosidase inhibitor. Diabetes Care 1997, 20:462.
18. Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Diabetes Care 1998, 21:256-260. 10.2337/diacare.21.2.256, 9539992.
19. Ouchi M, Oba K, Yamashita H, Okazaki M, Tsunoda M, Ohara M, Sekimizu K, Watanabe K, Suzuki T, Nakano H. Effects of sex and age on serum 1,5-anhydroglucitol in nondiabetic subjects. Exp Clin Endocrinol Diabetes 2012, 120:288-295.
20. Monnier L. Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?. Eur J Clin Invest 2000, 30(Suppl 2):3-11.
21. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012, 3:8-10.
22. Nakatou T, Nakata K, Nakamura A, Itoshima T. Carotid haemodynamic parameters as risk factors for cerebral infarction in Type 2 diabetic patients. Diabet Med 2004, 21:223-229. 10.1111/j.1464-5491.2004.01108.x, 15008831.
23. Nishiyama Y, Katsumata T, Otori T, Katayama Y. Carotid hemodynamic parameters are useful for discriminating between atherothrombotic infarction and lacunar infarction. J Stroke Cerebrovasc Dis 2010, 19:441-449. 10.1016/j.jstrokecerebrovasdis.2009.08.005, 20619678.
24. Lee MY, Wu CM, Chu CS, Lee KT, Sheu SH, Lai WT. Association of carotid hemodynamics with risk of coronary heart disease in a Taiwanese population with essential hypertension. Am J Hypertens 2008, 21:696-700. 10.1038/ajh.2008.160, 18437128.
25. Koivistoinen T, Virtanen M, Hutri-Kähönen N, Lehtimäki T, Jula A, Juonala M, Moilanen L, Aatola H, Hyttinen J, Viikari JS, Raitakari OT, Kähönen M. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis 2012, 220:387-393. 10.1016/j.atherosclerosis.2011.08.007, 21871623.
26. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003, 26:615-622. 10.1291/hypres.26.615, 14567500.
27. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121:505-511. 10.1161/CIRCULATIONAHA.109.886655, 2836717, 20083680.
28. Simons PCG, Algra A, Bots ML, Grobbee D, van der Graaf Y. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients: the SMART Study (Second Manifestations of ARTerial disease). Circulation 1999, 100:951-957. 10.1161/01.CIR.100.9.951, 10468526.
29. Li CH, Wu JS, Yang YC, Shin CC, Lu FH, Chang CJ. Increase arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose. J Clin Endocrionl Metab 2012, 97:E658-E662.
30. Huang CL, Chen MF, Jeng JS, Lin LY, Wang WL, Feng MH, Liau CS, Hwang BS, Lee YT, Su TC. Postchallenge hyperglycaemic spike associate with arterial stiffness. Int J Clin Pract 2007, 61:397-402. 10.1111/j.1742-1241.2006.01227.x, 17313605.
31. Ledoux J, Werner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 2006, 21:69-78.
32. Graier WF, Simecek S, Kukovetz WR, Kostner GM. High d-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 1996, 45:1386-1395. 10.2337/diabetes.45.10.1386, 8826976.
33. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96:25-28. 10.1161/01.CIR.96.1.25, 9236411.
34. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious on endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008, 57:1349-1354. 10.2337/db08-0063, 18299315.
35. Azuma K, Kawamori R, Toyofuku Y, Kitahara Y, Sato F, Shimizu T, Miura K, Mine T, Tanaka Y, Mitsumata M, Watada H. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006, 26:2275-2280. 10.1161/01.ATV.0000239488.05069.03, 16888238.
36. Ge QM, Dong Y, Zhang HM, Su Q. Effects of intermittent high glucose on oxidative stress in endothelial cells. Acta Diabetol 2010, 47(Suppl 1):97-103.
37. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H. Hyperglycemia rapidly suppresses flow-mediated endothelial-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999, 34:146-154. 10.1016/S0735-1097(99)00168-0, 10400004.
38. Konukoglu D, Hatemi H, Ozer EM, Gonen S, Akcay T. The erythrocyte glutathione levels during oral glucose tolerance test. J Endocrinol Invest 1997, 20:471-475.
39. Xiang GD, Sun HL, Hou J, Yue L, Xu L. Acute hyperglycemia rapidly suppresses endothelium-dependent arterial dilation in first-degree relatives of type 2 diabetic patients. Exp Clin Endocrinol Diabetes 2008, 116:112-117. 10.1055/s-2007-984478, 18286427.
40. Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L, Taboga C. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Invest 1998, 28:329-333. 10.1046/j.1365-2362.1998.00295.x, 9615913.
41. Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L, Taboga C. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998, 21:1529-1533. 10.2337/diacare.21.9.1529, 9727904.
42. Yamanouchi T, Tachibana Y, Akanuma H, Minoda S, Shinohara T, Moromizato H, Miyashita H, Akaoka I. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol 1992, 263:E268-E273.